Gaze MN - Search Results

1

68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.

Gains JE, Aldridge MD, Mattoli MV, Bomanji JB, Biassoni L, Shankar A, Gaze MN. Gains JE, et al. Among authors: gaze mn. Nucl Med Commun. 2020 Nov;41(11):1169-1177. doi: 10.1097/MNM.0000000000001265. Nucl Med Commun. 2020. PMID: 32796449

2

Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.

Bomanji JB, Gacinovic S, Gaze MN, Costa DC, Ell PJ. Bomanji JB, et al. Among authors: gaze mn. Br J Radiol. 1998 Jan;71(841):87-9. doi: 10.1259/bjr.71.841.9534706. Br J Radiol. 1998. PMID: 9534706

3

Functional imaging as an aid to decision-making in metastatic paraganglioma.

Bomanji JB, Hyder SW, Gaze MN, Gacinovic S, Costa DC, Coulter C, Ell PJ. Bomanji JB, et al. Among authors: gaze mn. Br J Radiol. 2001 Mar;74(879):266-9. doi: 10.1259/bjr.74.879.740266. Br J Radiol. 2001. PMID: 11338105

4

Treatment of neuroendocrine tumours in adults with 131I-MIBG therapy.

Bomanji JB, Wong W, Gaze MN, Cassoni A, Waddington W, Solano J, Ell PJ. Bomanji JB, et al. Among authors: gaze mn. Clin Oncol (R Coll Radiol). 2003 Jun;15(4):193-8. doi: 10.1016/s0936-6555(02)00273-x. Clin Oncol (R Coll Radiol). 2003. PMID: 12846498 Review.

5

Dosimetry for fractionated (131)I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary results.

Buckley SE, Saran FH, Gaze MN, Chittenden S, Partridge M, Lancaster D, Pearson A, Flux GD. Buckley SE, et al. Among authors: gaze mn. Cancer Biother Radiopharm. 2007 Feb;22(1):105-12. doi: 10.1089/cbr.2007.301. Cancer Biother Radiopharm. 2007. PMID: 17627418 Clinical Trial.

6

Clinical applications of dosimetry for mIBG therapy.

Flux GD, Chittenden SJ, Saran F, Gaze MN. Flux GD, et al. Among authors: gaze mn. Q J Nucl Med Mol Imaging. 2011 Apr;55(2):116-25. Q J Nucl Med Mol Imaging. 2011. PMID: 21386786 Review.

7

18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.

Papathanasiou ND, Gaze MN, Sullivan K, Aldridge M, Waddington W, Almuhaideb A, Bomanji JB. Papathanasiou ND, et al. Among authors: gaze mn. J Nucl Med. 2011 Apr;52(4):519-25. doi: 10.2967/jnumed.110.083303. Epub 2011 Mar 18. J Nucl Med. 2011. PMID: 21421719 Free article.

8

177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma.

Gains JE, Bomanji JB, Fersht NL, Sullivan T, D'Souza D, Sullivan KP, Aldridge M, Waddington W, Gaze MN. Gains JE, et al. Among authors: gaze mn. J Nucl Med. 2011 Jul;52(7):1041-7. doi: 10.2967/jnumed.110.085100. Epub 2011 Jun 16. J Nucl Med. 2011. PMID: 21680680 Free article.

9

Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma.

Kosmin MA, Bomanji JB, Cork NJ, Shankar A, Gaze MN. Kosmin MA, et al. Among authors: gaze mn. Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):597-601. doi: 10.1007/s00259-011-2022-7. Epub 2012 Jan 4. Eur J Nucl Med Mol Imaging. 2012. PMID: 22215110

10

Results of a quality assurance review of external beam radiation therapy in the International Society of Paediatric Oncology (Europe) Neuroblastoma Group's High-risk Neuroblastoma Trial: a SIOPEN study.

Gaze MN, Boterberg T, Dieckmann K, Hörmann M, Gains JE, Sullivan KP, Ladenstein R. Gaze MN, et al. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):170-4. doi: 10.1016/j.ijrobp.2012.05.004. Epub 2012 Jun 30. Int J Radiat Oncol Biol Phys. 2013. PMID: 22749633 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page